The pGEM-T is 3kb in length, and contains the amplicin resistance gene, conferring selection of the plasmid in E. coli, and the ori site which is the bacterial origin of replication. The plasmid has multiple cloning sites as shown below. The coding sequence was inserted by TA cloning. Many E. coli strains are suitable for the propagation of this vector including JM109, DH5α and TOP10.
The coding sequence can be easily obtained by digesting the vector with proper restriction enzyme(s). The coding sequence can also be amplified by PCR with M13 primers, or primer pair SP6 and T7.
|Mouse NTRK1 ORF mammalian expression plasmid, C-GFPSpark tag||MG51103-ACG|
|Mouse NTRK1 ORF mammalian expression plasmid, C-OFPSpark / RFP tag||MG51103-ACR|
|Mouse NTRK1 ORF mammalian expression plasmid, C-Flag tag||MG51103-CF|
|Mouse NTRK1 ORF mammalian expression plasmid, C-His tag||MG51103-CH|
|Mouse NTRK1 ORF mammalian expression plasmid, C-Myc tag||MG51103-CM|
|Mouse NTRK1 ORF mammalian expression plasmid, C-HA tag||MG51103-CY|
|Mouse NTRK1 ORF mammalian expression plasmid, N-Flag tag||MG51103-NF|
|Mouse NTRK1 ORF mammalian expression plasmid, N-His tag||MG51103-NH|
|Mouse NTRK1 ORF mammalian expression plasmid, N-Myc tag||MG51103-NM|
|Mouse NTRK1 ORF mammalian expression plasmid, N-HA tag||MG51103-NY|
|Mouse NTRK1 natural ORF mammalian expression plasmid||MG51103-UT|
|Learn more about expression Vectors|
TRKA is a member of the neurotrophic tyrosine kinase receptor (NTKR) family. It is a membrane-bound receptor that, upon neurotrophin binding, phosphorylates itself and members of the MAPK pathway. Isoform TrkA-III promotes angiogenesis and has oncogenic activity when overexpressed. Isoform TrkA-I is found in most non-neuronal tissues. Isoform TrkA-II is primarily expressed in neuronal cells. TrkA-III is specifically expressed by pluripotent neural stem and neural crest progenitors. The presence of NTRK1 leads to cell differentiation and may play a role in specifying sensory neuron subtypes. Mutations in TRKA gene have been associated with congenital insensitivity to pain, anhidrosis, self-mutilating behavior, mental retardation and cancer. It was originally identified as an oncogene as it is commonly mutated in cancers, particularly colon and thyroid carcinomas. TRKA is required for high-affinity binding to nerve growth factor (NGF), neurotrophin-3 and neurotrophin-4/5 but not brain-derived neurotrophic factor (BDNF). Known substrates for the Trk receptors are SHC1, PI 3-kinase, and PLC-gamma-1. NTRK1 has a crucial role in the development and function of the nociceptive reception system as well as establishment of thermal regulation via sweating. It also activates ERK1 by either SHC1- or PLC-gamma-1-dependent signaling pathway. Defects in NTRK1 are a cause of congenital insensitivity to pain with anhidrosis and thyroid papillary carcinoma.